CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program
FDA Law Blog
DECEMBER 3, 2023
On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. covered insulin product or vaccine). CMS also provides manufacturers a “special opportunity” to get a preliminary (i.e.,
105 
Let's personalize your content